Loading...
OTC Markets
Totals
Securities
12,313
Dollar Vol
$381.2M
Share Vol
611M
Trades
51,155

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

ODYY
Odyssey Health Inc.

Common Stock

0.0129

0.00

0.00%

0.0107 / 0.013 (16900 x 20000)

Real-Time Best Bid & Ask: 10:13am 07/15/2025
Delayed (15 Min) Trade Data: 12:00am 07/14/2025

Odyssey Health Inc.

2300 West Sahara Avenue

Suite 800 - #4012

Las Vegas, NV 89102

Business Description
Odyssey is a medical company with a focus in the area of life-saving medical solutions. Odyssey's corporate mission is to create, acquire and develop distinct assets, intellectual property, and exceptional technologies that provide meaningful medical solutions. The company is focused on areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity.
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001626644
Fiscal Year End
7/31
Company Officers & Contacts
Joseph Michael Redmond
CEO, President

Gregory Gironda
COO

Christine Marie Farrell
CFO, Company Secretary

Erik Emerson
CCO

Board of Directors
Jerome Harold Casey
Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Joseph Michael Redmond
CEO, President

Ricky Wayne Richardson
Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Richardson has over 30 years of experience as a global operations and quality leader. He possesses operations and quality control experience that includes change management, multi-plant operations, financial management, supply chain/vendor management, strategic business development, start-up planning and execution, new product introductions and lean deployment. From November 2020 to present, Mr. Richardson currently is the Vice President of Quality and Continuous Improvement for Advanced Drainage Systems, which is an industry leader in the design and manufacturing of products supporting water management solutions. From September 2011 to October 2020, Mr. Richardson held positions at Danaher Corporation, a multi-billion dollar global manufacturer of Diagnostic, Life Sciences, Product Identification, Water Quality and Environmental/Applied Solutions products and services. His most recent positions included Corporate Director of Danaher Business Systems DBS Integration Regulatory Affairs and Compliance and Corporate Director, of DBS Operations and Lean. From February 2008 to July 2011, Mr. Richardson was Director of Operations, Continuous Improvement for Stryker Orthopaedics, a multi-billion dollar global manufacturer of Orthopaedics. Prior to this, Mr. Richardson held various positions at Bioject Medical Technologies, Inc., Baxter Healthcare and Texas Instruments. From 1984 to 1987 he was a Lieutenant, in Field Artillery, with the U.S. Army. He holds a B.S. degree in Engineering from the U.S. Military Academy, West Point, NY. As Director, Mr. Richardson shall be compensated with stock in accordance with the mutual agreement of the Board's compensation committee.

Other Company Insiders
Jonathan Lutz
Joseph Redmond
Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Turner Stone & Co.

12700 Park Central Dr

Suite 1400

Dallas, TX 75251

Securities Counsel
Brinen & Associates, LLC

90 Broad Street

Second Floor

New York, NY 10004

Profile Data
SIC - Industry Classification
3841 - Surgical and medical instruments
Incorporation Information
NV, US, 2014
Employees
4 as of 04/05/2024
Shell
No
Products and Services

Odyssey has two different technologies in research and development; the CardioMap® heart monitoring and screening device, and the Save a Life choking rescue device. To date, none of our product candidates have received regulatory clearance or approval for commercial sale.

Company Facilities

The Company has no owned or leased properties.

Company Notes
Formerly=Odyssey Group Intl Inc. until 5-2025
OTCQB Venture Market Logo
Joined OTCQB 10/2023
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.